Clonal Hematopoiesis and Risk of Incident Lung Cancer

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Assessing Lung Cancer Absolute Risk Trajectory based on a Polygenic Risk Model

(2021) Rayjean J. Hung et al.   CANCER RESEARCH

Association of Clonal Hematopoiesis With Incident Heart Failure

(2021) Bing Yu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank

(2021) Joseph D. Szustakowski et al.   NATURE GENETICS

DNMT3A and TET2 mutant Clonal Hematopoiesis May Drive a Proinflammatory State and Predict Enhanced Response to Immune Checkpoint Inhibitors

(2021) Abhay Singh Singh et al.   BLOOD

Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors

(2021) Wei Hong et al.   CANCER RESEARCH

Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model

(2021) Yen T. M. Nguyen et al.   CANCER SCIENCE

Exome sequencing and analysis of 454,787 UK Biobank participants

(2021) Joshua D. Backman et al.   NATURE

Clonal Hematopoiesis Is Associated With Higher Risk of Stroke

(2021) Romit Bhattacharya et al.   STROKE

Clonal hematopoiesis is associated with risk of severe Covid-19

(2021) Kelly L. Bolton et al.   Nature Communications

Integrating genomic features for non-invasive early lung cancer detection

(2020) Jacob J. Chabon et al.   NATURE

Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking

(2020) Ahmed A. Z. Dawoud et al.   LEUKEMIA

Tutorial: a guide to performing polygenic risk score analyses

(2020) Shing Wan Choi et al.   Nature Protocols

Inherited causes of clonal haematopoiesis in 97,691 whole genomes

(2020) Alexander G. Bick et al.   NATURE

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

(2020) Kelly L. Bolton et al.   NATURE GENETICS

Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies.

(2019) Madison Conces et al.   JOURNAL OF CLINICAL ONCOLOGY

Clonal Hematopoiesis

(2019) Peter Libby et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

PRSice-2: Polygenic Risk Score software for biobank-scale data

(2019) Shing Wan Choi et al.   GigaScience

Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis

(2019) Whitney E. Zahnd et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis

(2019) Alexander G. Bick et al.   CIRCULATION

Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens

(2018) Eric A. Severson et al.   BLOOD

Serum and blood based biomarkers for lung cancer screening: a systematic review

(2018) Gavin C. W. Chu et al.   BMC CANCER

Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays

(2018) Catherine C. Coombs et al.   CLINICAL CANCER RESEARCH

Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis

(2018) Christopher Maximilian Arends et al.   LEUKEMIA

Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors

(2018) Ryan N. Ptashkin et al.   JAMA Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression

(2017) Wen Pan et al.   IMMUNITY

Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study

(2017) David C. Muller et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

(2017) Paul M Ridker et al.   LANCET

The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors

(2017) Emma Lefrançais et al.   NATURE

Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches

(2016) Mark T. W. Ebbert et al.   BMC BIOINFORMATICS

Comprehensive genomic profiles of small cell lung cancer

(2015) Julie George et al.   NATURE

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Age-related mutations associated with clonal hematopoietic expansion and malignancies

(2014) Mingchao Xie et al.   NATURE MEDICINE

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

(2014) Giulio Genovese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes

(2014) Siddhartha Jaiswal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and biological implications of driver mutations in myelodysplastic syndromes

(2013) E. Papaemmanuil et al.   BLOOD

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Case-control studies: basic concepts

(2012) J. P. Vandenbroucke et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

(2011) Rafael Bejar et al.   NEW ENGLAND JOURNAL OF MEDICINE